The FDA is prepared to authorize a coronavirus vaccine before late-stage Phase Three clinical trials are complete, as long as officials are convinced that the benefits outweigh the risks.
Perhaps each ministry should consider having a close allegiance with the Ministry of Higher Education – perhaps appointing a deputy director general of academics in their respective fields so that there will be communication between universities and ministries.
Many people already have antibodies against Ad5, which could cause the immune system to attack the vector instead of responding to the coronavirus, making these vaccines less effective.
Russia has approved a Covid-19 vaccine, but scientists have expressed concern about the opaque development of the Sputnik V vaccine and the lack of mass testing.